2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …

RA Byrne, X Rossello, JJ Coughlan… - … Heart Journal: Acute …, 2024 - academic.oup.com
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

2018 ESC/EACTS Guidelines on myocardial revascularization

M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …

Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Dapagliflozin in myocardial infarction without diabetes or heart failure

S James, D Erlinge, RF Storey, DK McGuire… - NEJM …, 2024 - evidence.nejm.org
Background In patients with acute myocardial infarction (MI), therapies that could further
reduce the risk of adverse cardiovascular and metabolic outcomes are needed. Methods In …

2018 ESC/EACTS Guidelines on myocardial revascularization

FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Bleeding avoidance strategies in percutaneous coronary intervention

D Capodanno, DL Bhatt, CM Gibson, S James… - Nature Reviews …, 2022 - nature.com
For many years, bleeding has been perceived as an unavoidable consequence of strategies
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous …

Y Li, Z Liang, L Qin, M Wang, X Wang, H Zhang, Y Liu… - The Lancet, 2022 - thelancet.com
Background Previous randomised trials of bivalirudin versus heparin in patients with ST-
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …

JP Collet, H Thiele, E Barbato… - European heart …, 2021 - academic.oup.com
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year …

M Valgimigli, E Frigoli, S Leonardi, P Vranckx… - The Lancet, 2018 - thelancet.com
Summary Background The Minimizing Adverse Haemorrhagic Events by Transradial Access
Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess …

[HTML][HTML] 2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation

OL Barbarash, DV Duplyakov… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation |
Barbarash | Russian Journal of Cardiology Russian Journal of Cardiology eng | рус User ISSN …